Global HIV Prevention Drops After Aid Cuts, UN Warns

The global HIV response is facing one of its sharpest prevention setbacks in years after international aid cuts disrupted testing, PrEP access, condom distribution and community outreach programs across low- and middle-income countries.

The latest warning comes from new UNAIDS data showing that access to pre-exposure prophylaxis, known as PrEP, fell 38% between 2024 and 2025 across 62 reporting countries. Reuters reported that the number of people receiving PrEP dropped from 3.3 million to 2.1 million, leaving more than one million fewer people with access to one of the most effective HIV prevention tools.

The decline follows major disruptions to U.S. foreign aid under President Donald Trump, broader donor pullbacks and domestic funding gaps in countries already carrying high HIV burdens.

UNAIDS Data Shows a Sharp Prevention Shock

The procedural trigger is a new UNAIDS brief released ahead of a United Nations HIV/AIDS meeting, with early 2025 data showing prevention programs weakening even as treatment systems have proved more resilient.

According to the United Nations Office at Geneva, global development assistance fell 23% in 2025, the steepest drop on record. HIV testing also dropped 22% in high-burden settings, while condom funding was cut by more than 90% in some cases.

The Washington Post reported that the drop came after U.S. aid pauses and restructuring under Trump, along with cuts from other wealthy countries and funding shortfalls in affected nations.

UNAIDS data still shows progress in some areas. Global new HIV infections fell from 2.1 million in 2010 to 1.2 million in 2025, while AIDS-related deaths declined to 570,000, the lowest level in more than 30 years.

But prevention is now the weak point.

📰 Related: WHO Warns 40 Million Children Are Already Addicted — and 160 Countries Have No Nicotine Pouch Rules

PrEP, Testing and Community Services Took the Hardest Hit

The economic trigger is not only a lower headline aid number. It is where the cuts landed.

Treatment programs were partly protected because governments and donors prioritized keeping people already living with HIV on antiretroviral therapy. Reuters reported that the number of people receiving HIV treatment rose 2.7% to 32.1 million in 2025.

Prevention services did not hold up the same way.

PrEP access fell sharply. HIV testing declined in high-burden settings. Community-led organizations that reach sex workers, men who have sex with men, adolescent girls and other high-risk groups reported deep service cuts.

The Washington Post reported that UNAIDS found community-led PrEP delivery fell 50%, while services for men who have sex with men and sex workers fell by more than 80% in surveyed organizations.

That is the central risk: fewer tests today can mean fewer diagnoses tomorrow, and fewer diagnoses can delay treatment until infections have already spread.

📰 Related: World Cup 2026 and Infectious Disease — What Health Experts Are Actually Watching

Trump Aid Cuts Reopened the PEPFAR Debate

The political backdrop is the future of PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief, which has long been one of Washington’s most widely praised global health programs.

Reuters reported in April that U.S. figures showed HIV aid continued in some areas, but testing and diagnoses dropped after the administration’s foreign-aid pause and program restructuring. PEPFAR-supported antiretroviral treatment recipients fell in late 2025 compared with the prior year, while HIV testing and new diagnoses also declined.

The State Department has argued that the U.S. remains committed to global HIV work through more accountable partnerships and stronger country ownership. Public health experts counter that prevention programs are often the first to collapse when funding shifts suddenly because they rely heavily on local outreach, peer educators and community clinics.

The result is a difficult trade-off: treatment can be preserved in the short term while prevention quietly weakens underneath it.

📰 Related: Postpartum Hemorrhage Kills 43,000 Women a Year — and 95% of Deaths Are Preventable

Why the Prevention Decline Matters Now

The HIV response is entering a strange moment.

Science is improving just as financing is weakening. Long-acting prevention tools such as injectable PrEP and lenacapavir could make HIV prevention easier for people who struggle with daily pills, but those tools only change the epidemic if clinics, outreach workers and supply chains can actually deliver them.

UNAIDS warned earlier this year that the HIV response is at a tipping point. In a March prevention framework, the agency said global targets remain achievable but require scaled-up investment, domestic financing and wider prevention access.

The unique danger in this funding cycle is that the damage may not be visible immediately.

Treatment numbers can stay stable for a while because existing patients remain prioritized. But when testing, condoms, PrEP and community outreach shrink, the first signal may appear later as new infections rise in groups that were already difficult to reach.

What Happens Next for the Global HIV Response

The next phase will depend on whether governments replace lost donor funding quickly enough to prevent long-term backsliding.

Some countries are already increasing domestic HIV budgets, according to UNAIDS and Reuters. But many low-income countries cannot easily replace U.S. and European aid at the same scale, especially for prevention programs aimed at marginalized groups.

The most important indicators over the next year will be:

• whether PrEP access rebounds,
• whether HIV testing volumes recover,
• whether community-led services survive,
• and whether PEPFAR’s new structure preserves prevention, not only treatment.

Global health officials are now watching 2026 and 2027 data closely. If prevention gaps widen further, the world could lose ground just as new HIV prevention technology becomes more powerful.

Key Takeaways

• UNAIDS data shows global PrEP access fell 38% between 2024 and 2025 across 62 countries.
• HIV testing dropped 22% in high-burden settings.
• Condom funding was cut by more than 90% in some areas.
• HIV treatment remained more resilient, rising 2.7% to 32.1 million people.
• The biggest concern is delayed impact: weaker prevention today could mean more infections later.

Sources

• Reuters — Funding cuts drive sharp drop in HIV prevention, UNAIDS says
• Washington Post — Global HIV prevention declined after Trump aid cuts, U.N. finds
• United Nations Office at Geneva — Perilous moment threatens to reverse years of gains in HIV/AIDS response
• Reuters — U.S. HIV aid continued, but testing and diagnoses dropped
• UNAIDS — New Access Framework for the new era of HIV prevention

Also Read

• Scientists Race to Test Ebola Treatments as Congo Outbreak Spreads Into Displacement Camps
• Ebola Confirmed in Congo Camp of 30,000 — 676 Cases, 136 Deaths
• GLP-1 Drugs: The Promises and the Troubling Side Effects Nobody Told You About